Secondary |
Schizophrenia |
30.6% |
Insomnia |
15.7% |
Drug Use For Unknown Indication |
10.9% |
Epilepsy |
8.1% |
Schizophrenia, Disorganised Type |
7.7% |
Product Used For Unknown Indication |
5.2% |
Akathisia |
3.2% |
Delusion |
3.2% |
Hallucination |
3.2% |
Constipation |
2.8% |
Parkinsonism |
2.8% |
Psychotic Disorder |
2.4% |
Anxiety |
1.6% |
Dermatitis Allergic |
1.2% |
Prophylaxis |
0.8% |
Depressive Symptom |
0.4% |
|
Neuroleptic Malignant Syndrome |
17.5% |
Rhabdomyolysis |
15.0% |
Urinary Retention |
12.5% |
Parkinsonism |
10.0% |
Blood Lactate Dehydrogenase Increased |
7.5% |
Constipation |
7.5% |
Acute Hepatic Failure |
5.0% |
Bradykinesia |
5.0% |
Neurological Symptom |
5.0% |
Renal Failure Acute |
5.0% |
Overdose |
2.5% |
Somnolence |
2.5% |
Stupor |
2.5% |
Suicide Attempt |
2.5% |
|
Concomitant |
Schizophrenia |
37.0% |
Constipation |
12.6% |
Schizophrenia, Paranoid Type |
12.0% |
Autonomic Nervous System Imbalance |
5.6% |
Foetal Exposure During Pregnancy |
5.6% |
Product Used For Unknown Indication |
4.8% |
Insomnia |
4.5% |
Schizophrenia, Disorganised Type |
2.9% |
Bipolar Ii Disorder |
2.7% |
Vomiting |
2.3% |
Parkinsonism |
2.1% |
Crohn's Disease |
1.7% |
Dementia With Lewy Bodies |
1.2% |
Dermatitis |
0.8% |
Nasopharyngitis |
0.8% |
Smoking Cessation Therapy |
0.8% |
Threatened Labour |
0.8% |
Epilepsy |
0.6% |
Gastritis |
0.6% |
Hypotension |
0.6% |
|
Tremor |
12.7% |
Agitation |
8.9% |
Pyrexia |
7.6% |
Tri-iodothyronine Decreased |
7.6% |
Urinary Retention |
7.6% |
Off Label Use |
5.1% |
Pneumonia |
5.1% |
Psychotic Disorder |
5.1% |
White Blood Cell Count Increased |
5.1% |
Condition Aggravated |
3.8% |
Feeding Disorder Neonatal |
3.8% |
Ileus Paralytic |
3.8% |
Pancytopenia |
3.8% |
Parkinsonism |
3.8% |
Schizophrenia |
3.8% |
Aspartate Aminotransferase Increased |
2.5% |
Depression Suicidal |
2.5% |
Dermatitis |
2.5% |
Electrocardiogram Qt Prolonged |
2.5% |
Feeding Disorder |
2.5% |
|